Bank of New York Mellon Corp increased its holdings in shares of Alere Inc. (NYSE:ALR) by 10.4% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 431,675 shares of the medical research company’s stock after purchasing an additional 40,673 shares during the period. Bank of New York Mellon Corp owned 0.49% of Alere worth $21,665,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of the stock. Vanguard Group Inc. boosted its stake in Alere by 5.1% during the 1st quarter. Vanguard Group Inc. now owns 6,942,162 shares of the medical research company’s stock worth $275,813,000 after purchasing an additional 334,936 shares during the period. Goldman Sachs Group Inc. boosted its stake in Alere by 2.2% during the 1st quarter. Goldman Sachs Group Inc. now owns 763,211 shares of the medical research company’s stock worth $30,322,000 after purchasing an additional 16,572 shares during the period. Geode Capital Management LLC boosted its stake in Alere by 8.2% during the 1st quarter. Geode Capital Management LLC now owns 666,179 shares of the medical research company’s stock worth $26,466,000 after purchasing an additional 50,238 shares during the period. Marshall Wace LLP boosted its stake in Alere by 0.9% during the 1st quarter. Marshall Wace LLP now owns 645,520 shares of the medical research company’s stock worth $25,821,000 after purchasing an additional 5,893 shares during the period. Finally, Litespeed Management L.L.C. acquired a new stake in Alere during the 1st quarter worth $25,630,000. Hedge funds and other institutional investors own 88.76% of the company’s stock.

TRADEMARK VIOLATION WARNING: This report was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this report on another site, it was illegally stolen and republished in violation of international copyright laws. The original version of this report can be read at https://www.thecerbatgem.com/2017/09/16/bank-of-new-york-mellon-corp-acquires-40673-shares-of-alere-inc-alr.html.

Shares of Alere Inc. (ALR) opened at 49.76 on Friday. The stock has a 50 day moving average of $49.61 and a 200 day moving average of $47.13. Alere Inc. has a 1-year low of $34.41 and a 1-year high of $50.63. The firm’s market cap is $4.36 billion.

Several analysts have recently commented on ALR shares. BidaskClub cut shares of Alere from a “hold” rating to a “sell” rating in a research note on Wednesday, August 9th. Zacks Investment Research cut shares of Alere from a “hold” rating to a “sell” rating in a research note on Thursday, August 17th. Jefferies Group LLC restated a “hold” rating and issued a $51.00 target price on shares of Alere in a research note on Thursday, June 1st. Canaccord Genuity cut shares of Alere from a “buy” rating to a “hold” rating and set a $51.00 target price for the company. in a research note on Tuesday, June 6th. Finally, BTIG Research restated a “hold” rating on shares of Alere in a research note on Wednesday, May 24th. One research analyst has rated the stock with a sell rating and six have assigned a hold rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $48.00.

Alere Company Profile

Alere Inc is a provider of health information through diagnostic tests. The Company’s segments include professional diagnostics, consumer diagnostics, and corporate and other. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus.

Want to see what other hedge funds are holding ALR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Alere Inc. (NYSE:ALR).

Institutional Ownership by Quarter for Alere (NYSE:ALR)

Receive News & Stock Ratings for Alere Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alere Inc. and related stocks with our FREE daily email newsletter.